Back to All Speakers

Michael Fiore, MD MPH MBA

Director, Center for Tobacco Research and Intervention (CTRI), University of Wisconsin School of Medicine and Public Health

Michael Fiore founded and directs the University of the Wisconsin Center for Tobacco Research and Intervention and is a nationally recognized expert on tobacco use. He is widely published and chaired the panels that produced the 1996, 2000 and 2008 United States PHS Clinical Practice Guideline: Treating Tobacco Use and Dependence. He also chaired the HHS Subcommittee on Tobacco Cessation of the Interagency Committee on Smoking and Health, developing a national action plan for tobacco cessation in the U.S., and assisted the Justice Department in their landmark lawsuit against the tobacco industry. He has served as Principal Investigator on four consecutive NIH Center grants. His research addresses a broad array of tobacco control areas, with a focus on understanding and treating tobacco dependence among patients visiting healthcare settings. In 2012, Dr. Fiore was elected to the National Academy of Medicine (formerly, the Institute of Medicine). The National Cancer Institute selected Dr. Fiore as an inaugural recipient of an Outstanding Investigator Award in 2015.

Previous Sessions

Monday, May 23, 2016

National Treatment Guidelines Development and Implementation

The session addresses FCTC Article 14 implementation, especially in regard to national tobacco dependence treatment guidelines. The presenters, all of whom have been involved in the guideline development process, consider the history, challenges, and successes of developing national guidelines and make specific suggestions for accelerating this process.